BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 25, 2008
View Archived Issues
VCH-759 resistance mutations identified
Read More
PharmaGap reports results from animal studies of PhG-alpha1 for cancer
Read More
Lorus Therapeutics recaps Q3 highlights
Read More
AFM-13 acts according to expectations in preclinical studies
Read More
Pim kinase inhibitor SGI-1776 induces apoptosis in cancer cells
Read More
Monoclonal antibody against AMIGO-2 inhibits pancreatic tumor growth in vivo
Read More
La Jolla presents positive 12-month interim antibody data from phase III trial
Read More
Micromet enrolls first patient in a phase I BiTE antibody MT-110 trial
Read More
Oral PBI-1402 shows significant activity in chemotherapy-induced anemia
Read More
Pharming commences clinical program for Prodarsan in ageing diseases
Read More
FDA approves Vyvanse to treat adult ADHD
Read More
NovaRx's cancer vaccine enters phase III evaluation for NSCLC
Read More
Johnson & Johnson's SGLT2 inhibitor JNJ-28431754 to be evaluated in phase II studies
Read More
Lpath initiates dosing in phase I clinical trial of Asonep for cancer
Read More
Epeius presents results from phase I/II clinical trial of Rexin-G for pancreatic cancer
Read More
Sygnis receives E.U. orphan drug designation for AX-200 in ALS
Read More
Recent Tibotec patent reports novel anti-HIV agents
Read More
New anxiolytic and antidepressant agents disclosed in recent patent literature
Read More
Alpharma to withdraw and resubmit NDA to the FDA for Embeda
Read More
CHMP issues positive opinion for Medigene's rosacea drug Oracea
Read More
CHMP issues positive opinion for Neupro for restless legs syndrome
Read More
CHMP issues positive opinion for ranolazine for treatment of chronic angina
Read More
Recent patents describe novel therapeutic agents for neurological disorders
Read More
FDA approves Relistor for opioid-induced constipation
Read More
